Human Therapeutic Products Stocks List

Recent Signals

Date Stock Signal Type
2021-03-08 AMGN 20 DMA Resistance Bearish
2021-03-08 AMGN Shooting Star Candlestick Bearish
2021-03-08 AMGN Doji - Bearish? Reversal
2021-03-08 AMGN Lower Bollinger Band Walk Weakness
2021-03-08 AMGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-03-08 IRWD 50 DMA Resistance Bearish
2021-03-08 IRWD 200 DMA Resistance Bearish
2021-03-08 IRWD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-03-08 IRWD Pocket Pivot Bullish Swing Setup

Recent News for Human Therapeutic Products Stocks

Date Stock Title
Mar 6 IRWD The Past Week's Most Notable Insider Buys: Editas, Exxon Mobil, Wayfare And More
Mar 6 AMGN SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Five Prime Therapeutics, Inc. (Nasdaq - FPRX)
Mar 5 AMGN Amgen: 10-12% Upside Going Into March
Mar 5 AMGN Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout
Mar 5 AMGN ETFs to Tap Amgen's Drive for Cancer Deal
Mar 5 AMGN Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79%
Mar 5 AMGN Amgen Inc. (AMGN) Management Presents at Cowen 41st Annual Healthcare Conference (Transcript)
Mar 4 AMGN Amgen Acquires a Cancer Drug. Expect More Deals.
Mar 4 AMGN Amgen: One Of The Few Bargains In This Market
Mar 4 AMGN SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
Mar 4 AMGN Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
Mar 4 AMGN FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
Mar 4 AMGN Why Five Prime Therapeutics Stock Is Skyrocketing Today
Mar 4 AMGN Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
Mar 4 AMGN Amgen (AMGN) Down 5.5% Since Last Earnings Report: Can It Rebound?
Mar 4 AMGN Why Amgen's $1.9 Billion Takeover Might Only Whet Its Appetite In 2021
Mar 4 AMGN Amgen Boosts Cancer Drive With $1.9 Billion Five Prime Deal
Mar 4 AMGN Amgen to acquire Five Prime Therapeutics for $1.9B
Mar 4 AMGN Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
Mar 4 AMGN Amgen to Buy Five Prime for $1.9B to Boost Cancer-Drug Pipeline